Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Yeni Purnamasari

Yeni Purnamasari

Master Program in Biomedical Science, Faculty of Medicine Brawijaya University, Malang, East Java, Indonesia

Title: Coelomic Fluid Lumbricus rubellus as combination of 5-Fluoucil Has Role In Decreasing FAK and Calcium Intracellular Expression On Colorectal Cancer HT-29 Cell Line

Biography

Biography: Yeni Purnamasari

Abstract

Coelomic fluid of the earthworm had a lot of bioactive substances as therapeutic drug and anticancer effect that has been proven in many medical research.  The benefit of coelomic fluid as anticancer effect needs further investigation. This study aimed to investigate whether the coelomic fluid of the earthworm Lumbricus rubellus as combination of 5-Fluouracil has role in decreasing focal adhesion kinase (FAK) and calcium intracellular expression (iCa2-) on colorectal cancer HT-29 cell line. HT-29 cells were cultured by adding coelomic fluid with 5-Fluouracil (5,10, and 20 g/ml) and without 5-Fluouracil (0, 20 g/ml) for 24 hours. We assessed the percentage of FAK level using flowcytometri and iCa2+ using immune-fluorescence. The result showed that after treating HT-29 cells with combination of coelomic fluid and 5-Fluouracil in different concentration, the percentage FAK level significantly decreased in dose combination (p < 0.05) and iCa2+ percentage compare each groups was significantly differences (p< 0.05). Corelation between percentage FAK and iCa2+ showed that there is a strong correlation (R = 0.77). This suggest that treating combination coelomic fluid and 5-fluouracil in HT-29 cells made the decrease in FAK percentage and also followed by iCa2+ percentage. Our finding suggested that coelomic fluid of the earthworm Lumbricus rubellus could prove useful as a combination of 5-fluouracil in colorectal cancer therapy.